Approvals/TGA/APX-CIPROFLOXACIN ciprofloxacin 250 mg (as hydrochloride) tablet blister pack

Approved

STANDARD

APX-CIPROFLOXACIN ciprofloxacin 250 mg (as hydrochloride) tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2c3ef1b3e9f1d683
Product Name: APX-CIPROFLOXACIN ciprofloxacin 250 mg (as hydrochloride) tablet blister pack
Artg Id: 333619
Artg Name: APX-CIPROFLOXACIN ciprofloxacin 250 mg (as hydrochloride) tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2020-05-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

2c3ef1b3e9f1d683

Type

Standard